Cargando…

SAT-399 Baseline Characteristics from the Observational PARADIGHM Registry of Patients with Chronic Hypoparathyroidism

PARADIGHM is an actively recruiting, prospective, observational registry (NCT01922440/EUPAS16927). The primary objective is to evaluate the safety and effectiveness of recombinant human parathyroid hormone, rhPTH(1-84), treatment in patients with chronic hypoparathyroidism (HypoPT) under routine cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clarke, Bart L, Rejnmark, Lars, Ing, Steven W, Brandi, Maria Luisa, Björnsdottir, Sigridur, Hofbauer, Lorenz C, Houillier, Pascal, Khan, Aliya A, Levine, Michael A, Mannstadt, Michael, Shoback, Dolores M, Vokes, Tamara J, Zhang, Pinggao, Marelli, Claudio, Germak, John, Gittoes, Neil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208590/ http://dx.doi.org/10.1210/jendso/bvaa046.591

Ejemplares similares

The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics
por: Gittoes, Neil, et al.
Publicado: (2021)

SAT-400 Pregnancy Outcome in Women with Hypoparathyroidism:Aswedishpopulation-Based Cohort Study
por: Bjornsdottir, Sigridur, et al.
Publicado: (2020)

SAT-LB72 Design of the PaTH Forward Phase 2 Trial of TransCon PTH, a Long-Acting PTH, in Patients With Hypoparathyroidism
por: Khan, Aliya Aziz, et al.
Publicado: (2020)

MON-530 Hypoparathyroidism in Sweden
por: Kamal, Wafa, et al.
Publicado: (2019)

SAT232 Patients With Chronic Hypoparathyroidism Have Higher Risk Of Vertebral Fracture And Lower Risk Of Femoral Fracture Compared To Controls
por: Bjornsdottir, Sigridur, et al.
Publicado: (2023)

OR30-1 Safety and Efficacy of Recombinant Human Parathyroid Hormone 1-84 for the Treatment of Adults with Chronic Hypoparathyroidism: Six-Year Results of the RACE Study
por: Bilezikian, John, et al.
Publicado: (2019)

OR23-05 Log-term Efficacy And Safety Of Transcon PTH In Adults With Hypoparathyroidism: 52-week Results From The Open-label Extension Of The Phase 3 Pathway Trial
por: Clarke, Bart, et al.
Publicado: (2023)

OR21-1 The PaTH Forward Trial: Efficacy and Safety of TransCon PTH Through Week 84 for Adults With Hypoparathyroidism
por: Ahmed, Intekhab, et al.
Publicado: (2022)

SAT231 Next-generation Sequencing For Detection Of Underlying Genetic Causes Of Nonsurgical Hypoparathyroidism: Preliminary Results From A Sponsored Testing Program
por: Mannstadt, Michael, et al.
Publicado: (2023)

TransCon PTH as a Hormone Replacement Therapy for Patients with Hypoparathyroidism: 6-Month Update from the PaTH Forward Open-Label Extension
por: Rubin, Mishaela R, et al.
Publicado: (2021)

SAT234 Variations In Clinical Practice Patterns For Hypoparathyroidism
por: Deering, Kathleen L, et al.
Publicado: (2023)

SAT224 Nonsurgical Hypoparathyroidism: 40 Years After Diagnosis
por: Ilyse Kaplan, Leah, et al.
Publicado: (2023)

SAT220 Rare Case Of Pembrolizumab Induced Primary Hypoparathyroidism
por: Goud, Sarita G, et al.
Publicado: (2023)

MON-520 Symptoms, Comorbidities, and Treatment Satisfaction with Chronic Hypoparathyroidism: Findings from a 13-Country Patient Survey
por: Bollerslev, Jens, et al.
Publicado: (2019)

MON-519 Impact of Chronic Hypoparathyroidism on Work, Productivity, and Relationships: Findings from a 13-Country Patient and Caregiver Survey
por: Clarke, Bart, et al.
Publicado: (2019)

MON-521 Impact of Chronic Hypoparathyroidism on Health-Related Quality of Life: Findings from a 13-Country Patient Survey
por: Siggelkow, Heide, et al.
Publicado: (2019)

SAT-LB71 Is Late Diagnosis of Postsurgical Hypoparathyroidism the Rule, Not the Exception?
por: Fahrleitner-Pammer, Astrid, et al.
Publicado: (2020)

SAT237 AZP-3601, A Novel PTH 1 Receptor Agonist, Induces Rapid Reduction And Normalization Of Urinary Calcium In Chronic Hypoparathyroid Patients
por: Figueres, Lucile, et al.
Publicado: (2023)

OR07-03 Continuous Subcutaneous Delivery of RhPTH(1-84) by Pump in Adults with Hypoparathyroidism
por: Bove-Fenderson, Erin, et al.
Publicado: (2020)

SAT239 Deceased Donor Parathyroid Allotransplant For Sever Refractory Iatrogenic Hypoparathyroidism
por: Devon, Karen M, et al.
Publicado: (2023)

SAT-393 Cognitive Function Evaluation in an Italian Cohort of Patients with Post-Operative Hypoparathyroidism
por: Saponaro, Federica, et al.
Publicado: (2020)

SAT-389 Clinical and Biochemical Characterization of Risk Factors for Vertebral Fractures in Patients with Hypoparathyroidism
por: Formenti, Anna Maria, et al.
Publicado: (2020)

SAT-396 A Non-Surgical Animal Model of Hypoparathyroidism for Testing PTH Analogues
por: Ramezani-Pour, Narjes, et al.
Publicado: (2020)

SAT-354 Isolated Hypoparathyroidism: A Rare Initial Manifestation of Hereditary Hemochromatosis (HH)
por: Shaheen, Zainab, et al.
Publicado: (2020)

SAT222 More Than Skin Deep: A Case Of Psoriasis Associated With Hypoparathyroidism
por: Sheth, Grishma, et al.
Publicado: (2023)

SAT-335 New Onset Adult Idiopathic Primary Hypoparathyroidism Concomitant with Severe Aplastic Anemia
por: Galustian, Sophia, et al.
Publicado: (2020)

MON-523 Risk of Nephrolithiasis and Nephrocalcinosis in Patients with Chronic Hypoparathyroidism (HypoPT)
por: Chen, Kristina, et al.
Publicado: (2019)

SAT218 Refractory Hypocalcemia From Combined Autosomal Dominant Hypocalcemia Type 2 And Postsurgical Hypoparathyroidism
por: Sonmez Ince, Melda, et al.
Publicado: (2023)

SAT233 Clinical And Economic Burden Of Postsurgical Chronic Hypoparathyroidism: A US Medicare Retrospective Analysis
por: Noori, Wahidullah, et al.
Publicado: (2023)

SAT-368 CYP24A1 Mutation Masking Malignancy Mediated Hypercalcemia
por: Cheng, Cheng, et al.
Publicado: (2020)

MON-526 Risk of Cardiovascular (CV) Conditions in Patients with Chronic Hypoparathyroidism (HypoPT)
por: Chen, Kristina, et al.
Publicado: (2019)

SAT-357 First Case in Saudi Arabia Revealing Fahr Syndrome Secondary to Hypoparathyroidism: A Case Report
por: Khan, Soha, et al.
Publicado: (2020)

MON-LB091 An Overview of the Etiology, Clinical Manifestations, Management Strategies, and Complications of Hypoparathyroidism from the Canadian National Hypoparathyroidism Registry
por: Alalawi, Yousef, et al.
Publicado: (2019)

MON-522 Risk of Chronic Kidney Disease (CKD) and Its Progression in Patients with Chronic Hypoparathyroidism (HypoPT)
por: Chen, Kristina, et al.
Publicado: (2019)

SAT-342 Humerus Fracture & Dislocation of Right Shoulder Following a Seizure in Non-Epileptic Patient Due to Hypoparathyroidism
por: Doub, Najah Younes, et al.
Publicado: (2020)

SAT217 Chronic Asymptomatic Hypoparathyroidism Due To Two Separate Single Nucleotide Heterozygous Mutations In The CaSR Gene
por: Anto Antony, Mc, et al.
Publicado: (2023)

Serum Calcium Levels in Adult Patients With Chronic Hypoparathyroidism Treated With rhPTH(1–84) Compared With a Historical Control Cohort
por: Rejnmark, Lars, et al.
Publicado: (2021)

MON-524 Risk of Decline in Estimated Glomerular Filtration Rate (eGFR) in Patients with Chronic Hypoparathyroidism (HypoPT)
por: Chen, Kristina, et al.
Publicado: (2019)

Risk of Chronic Kidney Disease in Adult Patients With Chronic Hypoparathyroidism Treated With rhPTH(1–84) Compared With a Historical Control Cohort
por: Gosmanova, Elvira, et al.
Publicado: (2021)

SAT-408 Bioactivity of Long Acting PTH Fusion Molecules Tested in a Novel Non-Surgical Animal Model of Hypoparathyroidism
por: Wilkinson, Ian R, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_njdo2r1ihvlpj10hc15fq0v433